Smiths Medical, the Plymouth-based maker of hospital infusion pumps, confirmed earlier this month cybersecurity vulnerabilities in its Medfusion 4000 drug pumps, which are used in pediatric cases worldwide.
The company said Monday that it has received no reports of computer hackers exploiting the vulnerabilities.
The U.S. Homeland Security Department published an advisory Sept. 7 revealing that three versions of Smiths Medical's Medfusion 4000 drug infusion pump contain vulnerabilities that would allow a skilled computer hacker to remotely take control of the device and alter how it dispenses drugs.
Smiths Medical said it is working with Homeland Security and the Industrial Control Systems Cyber Emergency Response Team (ICS-CERT) on the issue and plans to roll out new software for versions 1.1, 1.5 and 1.6 in January.
"In the meantime," Smiths spokeswoman Meghan Cushing said via e-mail, "we've contacted our customers with actions they can take immediately to safeguard their devices, and continue safe delivery of fluids and medication."
On its website, Smiths Medical promotes the Medfusion 4000 pump for its ability to accurately dispense small doses of drugs in critical care situations, including in neonatal and pediatric intensive care.
Brett Landrum, Smiths Medical chief technology officer, apologized to Medfusion 4000 customers in a Sept. 7 letter, but noted that the chances of anyone actually exploiting the vulnerabilities was "highly unlikely."
A company spokeswoman confirmed Monday that no reports of malicious exploits have been received.